US Regulators Approve Novo Nordisk’s Wegovy, First Daily Pill For Weight Loss
The US Food and Drug Administration has approved the first daily pill for obesity, giving drugmaker Novo Nordisk an advantage over Eli Lilly in the race to offer an oral option for weight loss.